Thymic function, anti-thymocytes globulins, and cancer after renal transplantation
- 31 July 2011
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 25 (1), 56-60
- https://doi.org/10.1016/j.trim.2011.05.003
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Prolonged CD4 T Cell Lymphopenia Increases Morbidity and Mortality after Renal TransplantationJournal of the American Society of Nephrology, 2010
- Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft RejectionAmerican Journal of Transplantation, 2003
- CD4 Cell Lymphopenia and Atherosclerosis in Renal Transplant RecipientsJournal of the American Society of Nephrology, 2003
- Lymphocyte subsets and assessment of cancer risk in renal transplant recipientsTransplant International, 2002
- MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1Transplantation, 2001
- CD4 LYMPHOCYTOPENIA AS A RISK FACTOR FOR SKIN CANCERS IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1998
- Induction of Fas (Apo-1, CD95)-Mediated Apoptosis of Activated Lymphocytes by Polyclonal Antithymocyte GlobulinsBlood, 1998
- Persistent Long-Term Changes In Lymphocyte Subsets Induced By Polyclonal Antibodies1Transplantation, 1997
- A COMPREHENSIVE DEFINITION OF THE MAJOR ANTIBODY SPECIFICITIES IN POLYCLONAL RABBIT ANTITHYMOCYTE GLOBULIN1Transplantation, 1994
- ANTIBODIES AGAINST FUNCTIONAL LEUKOCYTE SURFACE MOLECULES IN POLYCLONAL ANTILYMPHOCYTE AND ANTITHYMOCYTE GLOBULINSTransplantation, 1991